Volatile Markets, Sarah, and Inflation.

Many of our clients will have noticed that some of their accounts have been accumulating cash during recent months, and that some of that cash has been used to purchase shares of securities during the past couple of weeks. This is according to plan. Normally, our clients hold securities which make periodic distributions of cash. Those distributions are not automatically… Read more →

Are You In a Personal Lifestyle Bubble?

Years ago when I first began doing cash flow analysis and planning with my clients I observed that we have a tendency to increase our outflows as our income increases. During the first annual review with one particular client the conversation went something like this: Me: It looks like your spending equals your income. You’re not spending more than you have,… Read more →

Automation: More of the Story.

Please forgive me for “harping” on this, but I think it is important in order to understand some aspects of today’s economic situation. ZDNet just published a good piece on the effects of automation. Automation in the 21st century could (at least partially) explain why inflation continues to be lower than “normal”, why your pay increases have been less than you expected, why… Read more →

A Change, Another Change, and Some More Changes.

The first change that I would like to tell you about has to do with my function as a Missouri insurance producer.¹ I have been a licensed Missouri insurance producer since 1979, licensed to kill. No, wait. That’s not right. That’s James Bond. My licenses allowed me to sell insurance products in the state of Missouri, but not to kill. As of… Read more →

2nd Quarter Reports and Some Wisdom from Honest Abe.

Our clients’ preliminary 2nd quarter reports have been posted. Final reports, including CPI information will replace the preliminary reports toward the end of the month. Of the twelve investment categories commonly used and shown below, eight were negative for the quarter. Investment Category Representative ETF 2015,Q2 iShares NASDAQ Biotechnology (IBB) 8.51 Vanguard Healthcare (VHT) 4.58 iShares Russell 1000 (IWB) 0.54… Read more →